BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 35487417)

  • 1. Orbital nodular fasciitis in child with biallelic germline RBL2 variant.
    Rips J; Abu-Libdeh B; Koplewitz BZ; Kehat-Ophir S; Frenkel S; Elpeleg O; Harel T
    Eur J Med Genet; 2022 Jun; 65(6):104513. PubMed ID: 35487417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High incidence of allelic loss at 16q12.2 region spanning RBL2/p130 gene in retinoblastoma.
    Priya K; Jada SR; Quah BL; Quah TC; Lai PS
    Cancer Biol Ther; 2009 Apr; 8(8):714-7. PubMed ID: 19252413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RBL2 bi-allelic truncating variants cause severe motor and cognitive impairment without evidence for abnormalities in DNA methylation or telomeric function.
    Samra N; Toubiana S; Yttervik H; Tzur-Gilat A; Morani I; Itzkovich C; Giladi L; Abu Jabal K; Cao JZ; Godley LA; Mory A; Baris Feldman H; Tveten K; Selig S; Weiss K
    J Hum Genet; 2021 Nov; 66(11):1101-1112. PubMed ID: 33980986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclin F drives proliferation through SCF-dependent degradation of the retinoblastoma-like tumor suppressor p130/RBL2.
    Enrico TP; Stallaert W; Wick ET; Ngoi P; Wang X; Rubin SM; Brown NG; Purvis JE; Emanuele MJ
    Elife; 2021 Dec; 10():. PubMed ID: 34851822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biallelic loss-of-function variants in RBL2 in siblings with a neurodevelopmental disorder.
    Brunet T; Radivojkov-Blagojevic M; Lichtner P; Kraus V; Meitinger T; Wagner M
    Ann Clin Transl Neurol; 2020 Mar; 7(3):390-396. PubMed ID: 32105419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RBL2/p130 is a direct AKT target and is required to induce apoptosis upon AKT inhibition in lung cancer and mesothelioma cell lines.
    Pentimalli F; Forte IM; Esposito L; Indovina P; Iannuzzi CA; Alfano L; Costa C; Barone D; Rocco G; Giordano A
    Oncogene; 2018 Jul; 37(27):3657-3671. PubMed ID: 29606701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene-expression analysis identifies novel RBL2/p130 target genes in endemic Burkitt lymphoma cell lines and primary tumors.
    De Falco G; Leucci E; Lenze D; Piccaluga PP; Claudio PP; Onnis A; Cerino G; Nyagol J; Mwanda W; Bellan C; Hummel M; Pileri S; Tosi P; Stein H; Giordano A; Leoncini L
    Blood; 2007 Aug; 110(4):1301-7. PubMed ID: 17485552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoter Methylation Status Modulate the Expression of Tumor Suppressor (RbL2/p130) Gene in Breast Cancer.
    Ullah F; Khan T; Ali N; Malik FA; Kayani MA; Shah ST; Saeed M
    PLoS One; 2015; 10(8):e0134687. PubMed ID: 26271034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FGFR1 Is Critical for RBL2 Loss-Driven Tumor Development and Requires PLCG1 Activation for Continued Growth of Small Cell Lung Cancer.
    Kim KB; Kim Y; Rivard CJ; Kim DW; Park KS
    Cancer Res; 2020 Nov; 80(22):5051-5062. PubMed ID: 32973083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-106a represses the Rb tumor suppressor p130 to regulate cellular proliferation and differentiation in high-grade serous ovarian carcinoma.
    Liu Z; Gersbach E; Zhang X; Xu X; Dong R; Lee P; Liu J; Kong B; Shao C; Wei JJ
    Mol Cancer Res; 2013 Nov; 11(11):1314-25. PubMed ID: 24045973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The emerging role of RBL2/p130 in multi-step retinoblastoma tumorigenesis.
    Cheah PY
    Cancer Biol Ther; 2009 Apr; 8(8):718-9. PubMed ID: 19276650
    [No Abstract]   [Full Text] [Related]  

  • 12. RBL2/DREAM-mediated repression of the Aurora kinase A/B pathway determines therapy responsiveness and outcome in p53 WT NSCLC.
    Duan L; Perez RE; Calhoun S; Maki CG
    Sci Rep; 2022 Jan; 12(1):1049. PubMed ID: 35058503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus core protein modulates pRb2/p130 expression in human hepatocellular carcinoma cell lines through promoter methylation.
    Mileo AM; Mattarocci S; Matarrese P; Anticoli S; Abbruzzese C; Catone S; Sacco R; Paggi MG; Ruggieri A
    J Exp Clin Cancer Res; 2015 Nov; 34():140. PubMed ID: 26576645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The tumor suppressor Rb and its related Rbl2 genes are regulated by Utx histone demethylase.
    Terashima M; Ishimura A; Yoshida M; Suzuki Y; Sugano S; Suzuki T
    Biochem Biophys Res Commun; 2010 Aug; 399(2):238-44. PubMed ID: 20650264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleosomes positioning around transcriptional start site of tumor suppressor (Rbl2/p130) gene in breast cancer.
    Farman FU; Iqbal M; Azam M; Saeed M
    Mol Biol Rep; 2018 Apr; 45(2):185-194. PubMed ID: 29417345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein arginine methyltransferase 5 (PRMT5) inhibition induces lymphoma cell death through reactivation of the retinoblastoma tumor suppressor pathway and polycomb repressor complex 2 (PRC2) silencing.
    Chung J; Karkhanis V; Tae S; Yan F; Smith P; Ayers LW; Agostinelli C; Pileri S; Denis GV; Baiocchi RA; Sif S
    J Biol Chem; 2013 Dec; 288(49):35534-47. PubMed ID: 24189068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectrum of germline
    Rojanaporn D; Boontawon T; Chareonsirisuthigul T; Thanapanpanich O; Attaseth T; Saengwimol D; Anurathapan U; Sujirakul T; Kaewkhaw R; Hongeng S
    Mol Vis; 2018; 24():778-788. PubMed ID: 30636860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-17-5p enhances pancreatic cancer proliferation by altering cell cycle profiles via disruption of RBL2/E2F4-repressing complexes.
    Zhu Y; Gu J; Li Y; Peng C; Shi M; Wang X; Wei G; Ge O; Wang D; Zhang B; Wu J; Zhong Y; Shen B; Chen H
    Cancer Lett; 2018 Jan; 412():59-68. PubMed ID: 28987387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. pRb2/p130: a new candidate for retinoblastoma tumor formation.
    De Falco G; Giordano A
    Oncogene; 2006 Aug; 25(38):5333-40. PubMed ID: 16936755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein expression of the RB-related gene family and SV40 large T antigen in mesothelioma and lung cancer.
    Modi S; Kubo A; Oie H; Coxon AB; Rehmatulla A; Kaye FJ
    Oncogene; 2000 Sep; 19(40):4632-9. PubMed ID: 11030152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.